U.S. Markets closed

Targeted Medical Pharma, Inc. (TRGM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.011-0.00 (-26.67%)
At close: 3:33PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue5,260.9417,112.3599,555.562
Cost of Revenue2,095.6812,216.5282,989.305
Gross Profit3,165.264,895.8316,566.257
Operating Expenses
Research Development12.317158.37228.605
Selling General and Administrative5,182.7167,348.41210,178.598
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-2,029.773-2,610.951-3,840.946
Income from Continuing Operations
Total Other Income/Expenses Net136.14611.059159.341
Earnings Before Interest and Taxes-1,893.627-2,599.892-3,670.716
Interest Expense1,173.5651,229.2891,229.289
Income Before Tax-3,067.192-3,829.181-3,670.716
Income Tax Expense-65.8285,666.902
Minority Interest-23.382-23.382-23.382
Net Income From Continuing Ops-3,043.81-3,895.009-9,337.618
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-3,043.81-3,895.009-9,337.618
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-3,043.81-3,895.009-9,337.618